ChromaDex takes Tru Niagen into Brazil with MyPharma2Go partnership 01-Sep-2022 By Stephen Daniells LA-based ChromaDex is partnering with MyPharma2Go Corporation to take Tru Niagen nicotinamide riboside into Brazil, focusing on reaching both consumers and Health Care Practitioners (HCPs).
ChromaDex passes research program milestone with 100th Niagen study 02-Feb-2022 By Hank Schultz ChromaDex has announced the publication of the 100th study under a research program centered on its Niagen ingredient.